TY - JOUR T1 - Management of acute decompensated heart failure JF - Canadian Medical Association Journal JO - CMAJ SP - 797 LP - 805 DO - 10.1503/cmaj.051620 VL - 176 IS - 6 AU - Larry A. Allen AU - Christopher M. O'Connor Y1 - 2007/03/13 UR - http://www.cmaj.ca/content/176/6/797.abstract N2 - Acute decompensated heart failure represents a heterogeneous group of disorders that typically present as dyspnea, edema and fatigue. Despite the high prevalence of this condition and its associated major morbidity and mortality, diagnosis can be difficult, and optimal treatment remains poorly defined. Identification of the acute triggers for the decompensation as well as noninvasive characterization of cardiac filling pressures and output is central to management. Diuretics, vasodilators, continuous positive airway pressure and inotropes can be used to alleviate symptoms. However, few agents currently available for the treatment of acute decompensated heart failure have been definitively shown in large prospective randomized clinical trials to provide meaningful improvements in intermediate-term clinical outcomes. Multiple novel therapies are being developed, but previous treatment failures indicate that progress in the management of acute decompensated heart failure is likely to be slow. ER -